These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Enhancing the Therapeutic Potential of Lee S; Kim OJ; Lee KO; Jung H; Oh SH; Kim NK Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096826 [TBL] [Abstract][Full Text] [Related]
4. Preventive CCL2/CCR2 Axis Blockade Suppresses Osteoclast Activity in a Mouse Model of Rheumatoid Arthritis by Reducing Homing of CCR2 Flegar D; Filipović M; Šućur A; Markotić A; Lukač N; Šisl D; Ikić Matijašević M; Jajić Z; Kelava T; Katavić V; Kovačić N; Grčević D Front Immunol; 2021; 12():767231. PubMed ID: 34925336 [TBL] [Abstract][Full Text] [Related]
5. Human mesenchymal stromal/stem cells acquire immunostimulatory capacity upon cross-talk with natural killer cells and might improve the NK cell function of immunocompromised patients. Cui R; Rekasi H; Hepner-Schefczyk M; Fessmann K; Petri RM; Bruderek K; Brandau S; Jäger M; Flohé SB Stem Cell Res Ther; 2016 Jul; 7(1):88. PubMed ID: 27388156 [TBL] [Abstract][Full Text] [Related]
6. The effect of mesenchymal stem cells on chemotaxis of osteoclast precursor cells. Sumi K; Abe T; Kunimatsu R; Oki N; Tsuka Y; Awada T; Nakajima K; Ando K; Tanimoto K J Oral Sci; 2018; 60(2):221-225. PubMed ID: 29925706 [TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells alleviate idiopathic pneumonia syndrome by modulating T cell function through CCR2-CCL2 axis. Cao M; Liu H; Dong Y; Liu W; Yu Z; Wang Q; Wang Q; Liang Z; Li Y; Ren H Stem Cell Res Ther; 2021 Jul; 12(1):378. PubMed ID: 34215321 [TBL] [Abstract][Full Text] [Related]
8. CCL2/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancers. Huang B; Lei Z; Zhao J; Gong W; Liu J; Chen Z; Liu Y; Li D; Yuan Y; Zhang GM; Feng ZH Cancer Lett; 2007 Jul; 252(1):86-92. PubMed ID: 17257744 [TBL] [Abstract][Full Text] [Related]
9. Improving hematopoietic recovery through modeling and modulation of the mesenchymal stromal cell secretome. Liu FD; Tam K; Pishesha N; Poon Z; Van Vliet KJ Stem Cell Res Ther; 2018 Oct; 9(1):268. PubMed ID: 30352620 [TBL] [Abstract][Full Text] [Related]
10. Monocyte chemotactic protein-1 promotes the myocardial homing of mesenchymal stem cells in dilated cardiomyopathy. Guo J; Zhang H; Xiao J; Wu J; Ye Y; Li Z; Zou Y; Li X Int J Mol Sci; 2013 Apr; 14(4):8164-78. PubMed ID: 23591836 [TBL] [Abstract][Full Text] [Related]
11. Mesenchymal Stem Cells Enhance Chemotaxis of Activated T Cells through the CCL2-CCR2 Axis In Vitro. Zhang YL; Qiao SK; Xing LN; Guo XN; Ren JH Bull Exp Biol Med; 2021 Dec; 172(2):263-269. PubMed ID: 34855085 [TBL] [Abstract][Full Text] [Related]
12. CCL2 But Not CCR2 Is Required for Spontaneous Articular Cartilage Regeneration Post-Injury. Jablonski CL; Leonard C; Salo P; Krawetz RJ J Orthop Res; 2019 Dec; 37(12):2561-2574. PubMed ID: 31424112 [TBL] [Abstract][Full Text] [Related]
13. CCL2 and CXCL12 Derived from Mesenchymal Stromal Cells Cooperatively Polarize IL-10+ Tissue Macrophages to Mitigate Gut Injury. Giri J; Das R; Nylen E; Chinnadurai R; Galipeau J Cell Rep; 2020 Feb; 30(6):1923-1934.e4. PubMed ID: 32049021 [TBL] [Abstract][Full Text] [Related]
14. CCL2/CCR2 axis induces hepatocellular carcinoma invasion and epithelial-mesenchymal transition in vitro through activation of the Hedgehog pathway. Zhuang H; Cao G; Kou C; Liu T Oncol Rep; 2018 Jan; 39(1):21-30. PubMed ID: 29115520 [TBL] [Abstract][Full Text] [Related]
15. Vascular Stem/Progenitor Cell Migration Induced by Smooth Muscle Cell-Derived Chemokine (C-C Motif) Ligand 2 and Chemokine (C-X-C motif) Ligand 1 Contributes to Neointima Formation. Yu B; Wong MM; Potter CM; Simpson RM; Karamariti E; Zhang Z; Zeng L; Warren D; Hu Y; Wang W; Xu Q Stem Cells; 2016 Sep; 34(9):2368-80. PubMed ID: 27300479 [TBL] [Abstract][Full Text] [Related]
16. MCP/CCR2 signaling is essential for recruitment of mesenchymal progenitor cells during the early phase of fracture healing. Ishikawa M; Ito H; Kitaori T; Murata K; Shibuya H; Furu M; Yoshitomi H; Fujii T; Yamamoto K; Matsuda S PLoS One; 2014; 9(8):e104954. PubMed ID: 25133509 [TBL] [Abstract][Full Text] [Related]
17. Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2. Ringe J; Strassburg S; Neumann K; Endres M; Notter M; Burmester GR; Kaps C; Sittinger M J Cell Biochem; 2007 May; 101(1):135-46. PubMed ID: 17295203 [TBL] [Abstract][Full Text] [Related]
18. CCL2, but not its receptor, is essential to restrict immune privileged central nervous system-invasion of Japanese encephalitis virus via regulating accumulation of CD11b(+) Ly-6C(hi) monocytes. Kim JH; Patil AM; Choi JY; Kim SB; Uyangaa E; Hossain FM; Park SY; Lee JH; Kim K; Eo SK Immunology; 2016 Oct; 149(2):186-203. PubMed ID: 27260136 [TBL] [Abstract][Full Text] [Related]
19. Glioma-derived CCL2 and CCL7 mediate migration of immune suppressive CCR2 Takacs GP; Kreiger CJ; Luo D; Tian G; Garcia JS; Deleyrolle LP; Mitchell DA; Harrison JK Front Immunol; 2022; 13():993444. PubMed ID: 36685592 [TBL] [Abstract][Full Text] [Related]
20. CCR2-overexpressing mesenchymal stem cells targeting damaged liver enhance recovery of acute liver failure. Xu R; Ni B; Wang L; Shan J; Pan L; He Y; Lv G; Lin H; Chen W; Zhang Q Stem Cell Res Ther; 2022 Feb; 13(1):55. PubMed ID: 35123561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]